Frontiers in oncology.

4 days ago · Research Topics. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies. The core function of a multidisciplinary team (MDT) is to bring together a group of healthcare professionals from different fields in order to determine patients' treatment plan. Most of head and neck cancer (HNC) units are currently led by MDTs that at least include ENT and maxillofacial surgeons, radiation and medical oncologists.Master protocols in oncology allow detection of specific signal pathways strongly associated with driver gene mutations, cancer cell growth, and progression . A basket trial is a particular type of master protocol that evaluates the efficacy and safety of a targeted therapy in multiple diseases that share a common molecular alteration ( 11 ) or …Frontiers in Oncology is an open access journal that covers all areas of cancer research, from epidemiology to therapeutics. It is led by Field Chief Editor Prof Giuseppe Giaccone and publishes original research, reviews, and perspectives in various specialty sections.

Breast cancer: miRNAs monitoring chemoresistance and systemic therapy. Shivam Singh 1 Heena Saini 2 Ashok Sharma 3 Subhash Gupta 1 V. G. Huddar 4 Richa Tripathi 2*. 1 Department of Radiation Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.

Preprint repository name [Preprint] (2008). Available at: https://persistent-url (Accessed March 15, 2018). Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies. They offer a succinct and clear summary of the topic, allowing readers to get up-to-date on new developments and/or emerging concepts, as well as discuss the following: 1) Different schools of thought or controversies, 2) Current research gaps, 3) Potential future developments in the field.

Editorial: Novel targets for ovarian cancer stem cells. Although ovarian cancer (OC) has been considered as a chemo-sensitive tumor type, the majority of patients develop chemoresistance, which drives tumor relapse within two years. Cumulative evidence supports that the presence of cancer stem cells (CSCs), in tumor residuals are …1 Center for Tumor Diagnosis & Therapy, Jinshan Hospital, Fudan University, Shanghai, China; 2 School of Life Science, University of Chinese Academy of Sciences, Beijing, China; 3 Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China; 4 Institute of Clinical Science, Zhongshan Hospital, Fudan University, Shanghai, China; 5 … Frontiers works with research institutions, libraries, consortia, and funders to support authors who want to publish in a Frontiers journal. A central invoicing platform removes the burden from authors and helps contribute to the growing number of research articles that are openly available to all. Organizations can become institutional members ... This section on Pharmacology of Anti-Cancer Drugs is devoted to the publication of high quality research concerning all aspects of cancer and benign neoplasm drug treatment. The scope of the specialty section encompasses studies related to drugs targeting tumor cells, but also the various components of the tumor microenvironment, including non ...

Add widgets

Browse the latest research topics in oncology, covering various aspects of cancer biology, diagnosis, treatment and prevention. Find articles on mitochondrial dysregulation, skull-base tumours, radiation therapy, immunotherapy, nanomaterials, and more.

1 Center for Tumor Diagnosis & Therapy, Jinshan Hospital, Fudan University, Shanghai, China; 2 School of Life Science, University of Chinese Academy of Sciences, Beijing, China; 3 Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China; 4 Institute of Clinical Science, Zhongshan Hospital, Fudan University, Shanghai, China; 5 …The Cardio-Oncology section of Frontiers in Cardiovascular Medicine is to provide a prime publication platform for this emerging field in medicine. It should speak to clinicians and researchers across the multiple diciplines that contribute to this field, including cardiology, oncology, hematology, radiation oncology, surgery, internal medicine, pediatrics, …3 days ago · Tracess B Smalley. Timothy H Tran. Frontiers in Oncology. doi 10.3389/fonc.2024.1394702. Part of a multidisciplinary journal, this section explores targetable intervenients in cancer signaling pathways and their application in drug development and therapeutics. Mar 30, 2017 ... Synthetic biology promises to revolutionize cancer care by offering permanent cures to patients with historically untreatable malignancies.Aug 18, 2020 · Chronic Stress Promotes Cancer Development. Stress is an inevitable part of life. Chronic stress on account of reasons like adversity, depression, anxiety, or loneliness/social isolation can endanger human health. Recent studies have shown that chronic stress can induce tumorigenesis and promote cancer development.

Frontiers in Oncology is a broad-scope, multidisciplinary journal covering all areas of cancer research to advance our knowledge of cancer epidemiology to improve diagnosis, therapeutics and ... Terms and conditions. Part of a multidisciplinary journal, this section explores new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence.See all (158) Learn more about Research Topics. Part of a multidisciplinary journal, this section explores all aspects of hematological malignancies, including acute and chronic leukemia, lymphoma and plasma and hematopoietic stem cell disorders.penelope jayne duerksen-hughes. Loma Linda University. Loma Linda, United States. Associate Editor. Gynecological Oncology. Part of a multidisciplinary journal, this section explores the development of a personalized and tailored approach to the prevention and treatment of gynecologic malignancies.Description. Frontiers in Oncology publishes articles on the most outstanding discoveries across the entire research spectrum of Oncology. The mission of Frontiers in Oncology is to bring all relevant Specialties in Oncology together on a single platform. Frontiers in Oncology is composed of the following Specialty Sections: Frontiers in Cancer ...We conducted a rapid bibliometric evaluation of TDM in oncology to capture a snapshot of research in this area over time and explore topics that reflect development in the field. Reports with the composite, indexed term ‘therapeutic drug monitoring’ in the title and abstract were extracted from MEDLINE (inception to August 2021).

If you’re in the market for a reliable and versatile off-road vehicle, then look no further than the Nissan Frontier 4×4. With its rugged design, powerful performance, and advanced...Apr 23, 2024 ... Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways. Rong Wang ...

Frontier Airlines is a popular low-cost carrier that offers budget-friendly travel options for those looking to explore new destinations without breaking the bank. With a focus on ...Perspective: rethinking therapeutic strategies in oncology. Immuno-oncology has revolutionized cancer care, drug development, the design of clinical trials, standard treatment paradigms, and the evaluation of response to therapy. These are all areas, however, that have not fully incorporated principles of tumor immunology.They should provide the following: 1) Discuss current advances and future directions, 2) Clear presentation of the authors’ perspective, 3) Accurate presentation and citations of other authors’ work, 4) May include original data as well as personal insights and opinions. sharon r pine. Division of Medical Oncology, Department of Medicine, School of Medicine, University of Colorado Anschutz Medical Campus. Aurora, United States. Assistant Field Chief Editor. Frontiers in Oncology. See all (60) Learn more about Research Topics. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies.Frontiers Books allows users to browse, free of charge, through the pages of Frontiers e-books and e-magazines or download the entire pdf. You may also purchase hardcopy issues as well as other academic literature. ... Keywords: head and neck cancer,­oncology,­methods,­Cancer

Arabic arabic keyboard

Giacomo Corrado. Enrico Vizza. Ignacio Zapardiel. Frontiers in Oncology. doi 10.3389/fonc.2024.1393707. Part of a multidisciplinary journal, this section explores the development of a personalized and tailored approach to the prevention and treatment of gynecologic malignancies.

Nov 15, 2022 ... "Structure Matters: A Call to Action," presented by Robert A. Winn, MD, Director and Lipman Chair in Oncology, VCU Massey Cancer Center.Frontiers has a community retraction protocol in place to retract papers where serious concerns have been raised and validated by the community that warrant retraction, including ethical concerns, honest errors or scientific misconduct. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting ...Gostaríamos de exibir a descriçãoaqui, mas o site que você está não nos permite.Browse the latest research topics in oncology, covering various aspects of cancer biology, diagnosis, treatment and prevention. Find articles on mitochondrial dysregulation, skull-base tumours, radiation therapy, immunotherapy, nanomaterials, and more.2 days ago · Guohui Cao. Hongtao Zhang. Juan Wang. Frontiers in Oncology. doi 10.3389/fonc.2024.1339955. 304 views. Part of a multidisciplinary journal, this section explores the impact of genetic aberrations in carcinogenesis, as well as in the progression and outcomes of cancer. This section provides broad mechanistic and translational insights into all aspects of cancer and its interaction with components of the tumor-microenvironment.Frontiers in Oncology ... Consult your physician. Privacy Notice | Terms and Conditions of Use ©2019 PROBIOMED S.A. de C.V. | Consult your physician.Immunobiology and Immunotherapeutics in Myelodysplastic Syndrome and Acute Myeloid Leukemia. Shyam Patel. Anna Aureli. Alessandro Isidori. Claudio Cerchione. 2,536 views. 2 articles. Part of a multidisciplinary journal, this section explores all aspects of hematological malignancies, including acute and chronic leukemia, lymphoma and plasma and ...Feb 1, 2024 ... The upcoming scientific Forum titled "New Frontiers in Cancer and Healthy Aging," organized by IBSA Foundation for Scientific Research in ...They offer a succinct and clear summary of the topic, allowing readers to get up-to-date on new developments and/or emerging concepts, as well as discuss the following: 1) Different schools of thought or controversies, 2) Current research gaps, 3) Potential future developments in the field.Another fast-growing research area in radiation oncology is radiomics which uses data-characterization algorithms to extract features from radiological images, detect patterns, and uncover cancer characteristics as images contain much more information than perceived by the imaging interpreter or the clinician.

Figure 1 Hierarchical divisive clustering of brain tumor patients, based on the collected features. The dendrogram reporting the clusters identified through divisive hierarchical clustering is reported. Gower distance is reported on the y axis and each single unit analyzed (i.e. patients) on the x axis.Jan 23, 2024 · 3 Department of Pathology and Laboratory Medicine, Brown University Warren Alpert Medical School, Providence, RI, United States. Editorial on the Research Topic. Expert opinions in genitourinary oncology. In the last decade we have seen an explosion in the development of new treatment options, diagnostic tools, and prognostic and predictive ... Research Topics. This section advances our understanding of thoracic malignancies, namely pleural tumors, thymic malignancies, lung and mediastinal tumors, lung carcinoids, chest wall tumors and tracheal tumors.Sep 5, 2022 ... We're addressing the challenge of immune evasion from two angles. Firstly, by finding novel ways to overcome the defensive mechanisms that ...Instagram:https://instagram. bargain ollie's outlet Background aims: The field of cell and gene therapy in oncology has moved rapidly since 2017 when the first cell and gene therapies, Kymriah followed by Yescarta, were …1 Hookipa Pharma Inc., New York, NY, United States; 2 Department of Biomedicine - Haus Petersplatz, Division of Experimental Virology, University of Basel, Basel, Switzerland; Engineered viral vectors represent a promising strategy to trigger antigen-specific antitumor T cell responses. Arenaviruses have been widely studied … nyc to martha's vineyard 4 days ago · Research Topics. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies. Frontiers has a community retraction protocol in place to retract papers where serious concerns have been raised and validated by the community that warrant retraction, including ethical concerns, honest errors or scientific misconduct. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting ... map with addresses Treatment effect on contrast-enhanced tumor (CET) was evaluated according to the response assessment in neuro-oncology (RANO) criteria for clinical trials . In addition, an automated software-based method developed in house was used to objectively calculate the CET volume (see below and Supplementary Appendix ). browser in browser liang qiao. Faculty of Medicine and Health, The University of Sydney. Sydney, Australia. Specialty Chief Editor. Gastrointestinal Cancers: Colorectal Cancer.Are you an oncology nurse looking to expand your knowledge and advance your career? Look no further than free online oncology nursing CEU courses. Online learning has revolutionize... free swx chat Treatment effect on contrast-enhanced tumor (CET) was evaluated according to the response assessment in neuro-oncology (RANO) criteria for clinical trials . In addition, an automated software-based method developed in house was used to objectively calculate the CET volume (see below and Supplementary Appendix ). Female breast cancer (BC) has surpassed lung cancer and today it is the most diagnosed type of cancer (2.3 million new cancer cases, representing 11.7% of all cancer cases). In terms of mortality, it ranks in 5 th place, with 685,000 deaths in 2020. For women, BC represents 1 in 4 cancer cases and accounts for 1 in 6 cancer deaths ( 1 ). t mobile unlock phone LetPub整理了最新的Frontiers in Oncology 期刊投稿经验， 期刊官方投稿网址，影响因子，审稿周期/时间，研究方向，SCI期刊分区，中国作者发表的文章等信息， ...Breast cancer: miRNAs monitoring chemoresistance and systemic therapy. Shivam Singh 1 Heena Saini 2 Ashok Sharma 3 Subhash Gupta 1 V. G. Huddar 4 Richa Tripathi 2*. 1 Department of Radiation Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India. watch chicago bears game live for free Introduction. Glioma is the most common neuroepithelial tumor of the cerebral nervous system ().Ki-67 labeling index (LI) is a nuclear antigen expressed only by proliferating cells ().Previous studies showed that Ki-67 LI was one of the vital biological behavior biomarkers in glioma and correlated with glioma grading and prognosis (3, …Yu Zhu. Jixiang Chu. Dan Luo. Hai-Long Dai. Chengde Liao. Frontiers in Oncology. doi 10.3389/fonc.2024.1394708. This section advances our understanding of thoracic malignancies, namely pleural tumors, thymic malignancies, lung and mediastinal tumors, lung carcinoids, chest wall tumors and tracheal tumors. houston to san antonio weixing dai. Shanghai Cancer Center, Fudan University. Shanghai, China. Associate Editor. Gastrointestinal Cancers: Colorectal Cancer. Part of a multidisciplinary journal, this section focuses on the investigation of tumorigenesis, prevention, early detection and treatment of colorectal neoplasia. james monroe home Artificial Intelligence (AI) has many possible applications in Oncology. One of the most promising is the potential for AI to represent and/or infer processes from real-world data. On one hand, the availability of the pattern of care is growing in opportunities (e.g. new markers, devices, drugs, etc.), constraints (guidelines, protocols, legal issues), and needs (e.g. investments, sustainable ... sign in hulu.com Frontiers works with research institutions, libraries, consortia, and funders to support authors who want to publish in a Frontiers journal. A central invoicing platform removes the burden from authors and helps contribute to the growing number of research articles that are openly available to all. Organizations can become institutional members ... puebla tijuana 3 days ago · Tracess B Smalley. Timothy H Tran. Frontiers in Oncology. doi 10.3389/fonc.2024.1394702. Part of a multidisciplinary journal, this section explores targetable intervenients in cancer signaling pathways and their application in drug development and therapeutics. Perspective: rethinking therapeutic strategies in oncology. Immuno-oncology has revolutionized cancer care, drug development, the design of clinical trials, standard treatment paradigms, and the evaluation of response to therapy. These are all areas, however, that have not fully incorporated principles of tumor immunology.Yunmei Wang. Frontiers in Oncology. doi 10.3389/fonc.2024.1325362. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies.